In a murine model, MDSCs could preserve graft-versus-leukemia/tumor effects while attenuating GVHD, and it found that MDSCs functioned through regulating the Th17/Treg signaling pathway or inducing NKG2D+CD8+T cells [9,31,32]. Here, KLRK1 is linked to graft versus host disease.